FoxO3 restricts liver regeneration by suppressing the proliferation of hepatocytes.

Authors:
Liang CQ; Zhou DC; Peng WT; Chen WY; Wu HY and 9 more

Journal:
NPJ Regen Med

Publication Year: 2022

DOI:
10.1038/s41536-022-00227-6

PMCID:
PMC9232540

PMID:
35750775

Journal Information

Full Title: NPJ Regen Med

Abbreviation: NPJ Regen Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"rna sequencing data have been deposited in ncbi sequence read archive (sra) under the accession code srp224045.; rna-sequencing data have been deposited in ncbi sequence read archive (sra) under the accession code srp224045."

Code Sharing
Evidence found in paper:

"Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"This work was supported by grants from the National Key R&D Program of China (2017YFA0103302 and 2016YFE0204700), the National Natural Science Foundation of China (91649203, 82070257, 81770240, 81570222, 31802025, and 81270183), the Guangdong Natural Science Funds for Distinguished Young Scholar (2014A030306011), the Guangdong Science and Technology Planning Project (2014A050503043), the New Star of Pearl River on Science and Technology of Guangzhou (2014J2200002), the Top Young Talents of Guangdong Province Special Support Program (87315007), the Fundamental Research Funds for the Central Universities (21617436), and the Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University (ZSYX-M-2019-00009, ZSYXM202004, and ZSYXM202104), China."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025